12 Healthcare Stocks Moving In Wednesday's Pre-Market Session

 

Gainers

  • Kazia Therapeutics KZIA shares rose 18.62% to $11.72 during Wednesday's pre-market session. The company's market cap stands at $84.5 million.
  • BELLUS Health BLU stock moved upwards by 8.78% to $2.6. The market value of their outstanding shares is at $156.7 million. As per the press release, Q3 earnings came out 4 days ago.
  • Liminal Biosciences LMNL stock rose 7.23% to $4.15. The market value of their outstanding shares is at $97.1 million. As per the press release, Q3 earnings came out 4 days ago.
  • Chiasma CHMA stock moved upwards by 6.93% to $4.32. The company's market cap stands at $182.5 million.
  • BioNTech BNTX stock rose 6.77% to $92.82. The market value of their outstanding shares is at $21.0 billion.
  • Moleculin Biotech MBRX stock rose 6.12% to $0.84. The company's market cap stands at $50.7 million. The company's, Q3 earnings came out 4 days ago.

 

 

Losers

 

  • Oncternal Therapeutics ONCT stock fell 26.33% to $3.05 during Wednesday's pre-market session. The market value of their outstanding shares is at $52.8 million.
  • Interpace Biosciences IDXG shares declined by 16.94% to $2.65. The company's market cap stands at $10.6 million.
  • Alterity Therapeutics ATHE stock declined by 12.11% to $1.96. The market value of their outstanding shares is at $28.5 million.
  • Sonoma Pharmaceuticals SNOA shares declined by 9.45% to $7.0. The market value of their outstanding shares is at $12.4 million.
  • Obalon Therapeutics OBLN stock declined by 7.59% to $0.82. The company's market cap stands at $6.3 million.
  • Evogene EVGN shares decreased by 6.67% to $2.8. The market value of their outstanding shares is at $72.1 million. As per the press release, Q3 earnings came out today.

 

 

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: Pre-Market OutlookMarketsMovershealthcare stocksTop Gainers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!